| abstract |
Glycerophospholipids or salts, conjugates and derivatives thereof, in particular phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidyl-inositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA) And lipid preparations comprising polyunsaturated fatty acid (PUFA) acyl groups, in particular long-chain polyunsaturated fatty acid (LC-PUFA) acyl groups, such as omega-3 and / or omega-6 acyl groups, wherein the PUFA Is covalently bound to the glycerophospholipid. The disclosed formulations have improved bioactivity and are useful for the treatment of various cognitive and mental states and disorders and for maintaining the normal function of brain-related systems and processes such as ADHD. |